Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial-Reference-Cited by-同舟云学术

Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial

Published:2015-09 Issue:9999 Volume:386 Page:1156-1164
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Pritchard-Jones Kathy,Bergeron Christophe,de Camargo Beatriz,van den Heuvel-Eibrink Marry M,Acha Tomas,Godzinski Jan,Oldenburger Foppe,Boccon-Gibod Liliane,Leuschner Ivo,Vujanic Gordan,Sandstedt Bengt,de Kraker Jan,van Tinteren Harm,Graf Norbert

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Malignant renal tumours incidence and survival in European children (1978–1997): report from the Automated Childhood Cancer Information System project;Pastore;Eur J Cancer,2006

2. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial;de Kraker;Lancet,2004

3. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01;Graf;Eur J Cancer,2012

4. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group;Green;J Clin Oncol,1998

5. Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial;Pritchard-Jones;Ann Oncol,2012

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Profile and Outcomes of Childhood Wilms Tumors Treated in a Tertiary Cancer Center from North India;South Asian Journal of Cancer;2024-09-03

2. Multimodality detection of tumour rupture in children with Wilms tumour;Pediatric Blood & Cancer;2024-08-08

3. Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG);British Journal of Cancer;2024-07-30

4. UNC13B regulates the sensitivity of Wilms' tumor cells to doxorubicin by modulating lysosomes;Oncology Letters;2024-07-22

5. Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30‐year SIOP‐RTSG experience;Pediatric Blood & Cancer;2024-01-07